Biotech Investing BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS Patient
Biotech Investing Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Biotech Investing argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
Biotech Investing Cizzle Brands Adds Vertical Integration With $83.75M Acquisition of Flow Water Inc.; Secures Minimum Volume Commitments worth $184M in Manufacturing Contracts
Biotech Investing Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab in Osteogenesis Imperfecta
